Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-31 @ 10:15 AM
Study NCT ID:
NCT02383134
Status:
UNKNOWN
Last Update Posted:
2015-05-13
First Post:
2015-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Maximal Distance for Successful Supraclavicular Block
Sponsor:
Tunisian Military Hospital
Organization:
Study Overview
Official Title:
The Maximum Effective Needle-to-Nerve Distance for Anesthetic Ultrasound-Guided Supraclavicular Brachial Plexus Block
Status:
UNKNOWN
Status Verified Date:
2015-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The achievement of peripheral nerve block requires several needle passes, with each of them being at risk of causing nerve injury either by direct trauma or intraneural injection even with the use of the ultrasound.
The ultrasound guided supraclavicular brachial plexus block is known to be at risk of pneumothorax and / or nerve injury.
This study is designed to determine the maximal effective distance away from the nerve for the injection to be effective.
The ultrasound guided supraclavicular brachial plexus block is known to be at risk of pneumothorax and / or nerve injury.
This study is designed to determine the maximal effective distance away from the nerve for the injection to be effective.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: